Search research articles
Contact Us
Filters
Showing results (411-420 of 456) with videos related to
Page
of 46
Sort By:
Plos One
|
May 6, 2020
Changes of Fusarium oxysporum f.sp. lactucae levels and soil microbial community during soil biosolarization using chitin as soil amendment
Tara E Randall, Jesus D Fernandez-Bayo, Duff R Harrold, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 2015
Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa
Dorit Cohen, Undine Mechold, Hadas Nevenzal, et al.
Antiviral Research
|
November 4, 2015
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus
Laura K McMullan, Mike Flint, Julie Dyall, et al.
Gynecologic Oncology
|
October 4, 2011
Cervical cancer survival for patients referred to a tertiary care center in Kentucky
Leigh G Seamon, Rebecca L Tarrant, Steve T Fleming, et al.
Antimicrobial Agents and Chemotherapy
|
May 5, 2010
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV
E Randall Lanier, Roger G Ptak, Bernhard M Lampert, et al.
Plos Medicine
|
August 1, 2008
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
Jeffrey A Johnson, Jin-Fen Li, Xierong Wei, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
Thomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2004
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
Edwin DeJesus, Gisela Herrera, Eugenio Teofilo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 9, 2013
STAT2 deficiency and susceptibility to viral illness in humans
Sophie Hambleton, Stephen Goodbourn, Dan F Young, et al.
Journal of Paediatrics and Child Health
|
August 11, 2018
Evaluation of national guidelines for bronchiolitis: AGREEments and controversies
Diana Cavaye, Daniel P Roberts, Gemma L Saravanos, et al.
Page
of 46
Search research articles
Search
Showing results (411-420 of 456) with videos related to
Sort By:
Page
of 46
Plos One
|
May 6, 2020
Changes of Fusarium oxysporum f.sp. lactucae levels and soil microbial community during soil biosolarization using chitin as soil amendment
Tara E Randall, Jesus D Fernandez-Bayo, Duff R Harrold, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 2015
Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa
Dorit Cohen, Undine Mechold, Hadas Nevenzal, et al.
Antiviral Research
|
November 4, 2015
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus
Laura K McMullan, Mike Flint, Julie Dyall, et al.
Gynecologic Oncology
|
October 4, 2011
Cervical cancer survival for patients referred to a tertiary care center in Kentucky
Leigh G Seamon, Rebecca L Tarrant, Steve T Fleming, et al.
Antimicrobial Agents and Chemotherapy
|
May 5, 2010
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV
E Randall Lanier, Roger G Ptak, Bernhard M Lampert, et al.
Plos Medicine
|
August 1, 2008
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
Jeffrey A Johnson, Jin-Fen Li, Xierong Wei, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 29, 2005
Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
Thomas B Campbell, Nancy S Shulman, Steven C Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2004
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
Edwin DeJesus, Gisela Herrera, Eugenio Teofilo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 9, 2013
STAT2 deficiency and susceptibility to viral illness in humans
Sophie Hambleton, Stephen Goodbourn, Dan F Young, et al.
Journal of Paediatrics and Child Health
|
August 11, 2018
Evaluation of national guidelines for bronchiolitis: AGREEments and controversies
Diana Cavaye, Daniel P Roberts, Gemma L Saravanos, et al.
Page
of 46